Lexicon Pharmaceuticals, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011
Revenue & cost
Revenue 10.70M4.91M1.85M
Operating items
Research & Development 81.24M78.52M91.83M
Selling, General & Administrative 19.42M19.40M17.35M
Restructuring Costs 2.71M6.77M
Operating Expenses 100.66M100.63M115.94M
Operating Income -89.96M-95.72M-114.09M
EBIT -89.96M-95.72M-114.09M
Non-operating items
Non Operating Investment Income 1.17M0.14M
Interest & Investment Income 0.88M0.52M0.26M
Other Non Operating Income -2.55M-4.02M0.15M
Non Operating Income -2.55M-4.02M0.15M
Net income details
EBT -93.42M-101.80M-116.22M
Tax Provisions -0.10M-0.03M
Profit After Tax -93.32M-101.78M-116.22M
Income from Non-Controlling Interests -10.54M
Income from Continuing Operations -93.32M-101.78M-116.22M
Consolidated Net Income -93.32M-101.78M-116.22M
Income towards Parent Company -93.32M-101.78M-116.22M
Net Income towards Common Stockholders -93.32M-101.78M-116.22M
Additional items
EPS (Basic) -0.57-0.34-0.34
Shares Outstanding (Weighted Average) 25.10M48.22M48.24M
EBITDA -89.96M-95.72M-114.09M
Interest Expenses 2.97M2.72M2.53M
Tax Rate 0.11%0.03%